v3.24.2
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit - USD ($)
$ in Thousands
Total
Warrants, Reverse Recapitalization
Convertible Notes, Reverse Recapitalization
Convertible Notes, Reverse Recapitalization, Interest Forfeit
Previously Reported
Retroactive application of reverse recapitalization
Series 1 Preferred Stock
Redeemable Convertible Preferred Stock
Series G Preferred Stock
Series H Preferred Stock
Common Stock
Common Stock
Warrants, Reverse Recapitalization
Common Stock
Convertible Notes, Reverse Recapitalization
Common Stock
Previously Reported
Common Stock
Retroactive application of reverse recapitalization
Common Stock
Redeemable Convertible Preferred Stock
Additional Paid-In Capital
Additional Paid-In Capital
Warrants, Reverse Recapitalization
Additional Paid-In Capital
Convertible Notes, Reverse Recapitalization
Additional Paid-In Capital
Convertible Notes, Reverse Recapitalization, Interest Forfeit
Additional Paid-In Capital
Previously Reported
Additional Paid-In Capital
Retroactive application of reverse recapitalization
Additional Paid-In Capital
Redeemable Convertible Preferred Stock
Accumulated Deficit
Accumulated Deficit
Previously Reported
Beginning balance (in shares) at Apr. 24, 2022 [1] 18,644,339       10,085,612 8,558,727                                      
Beginning balance at Apr. 24, 2022 $ 52,218       $ 52,218                                        
Increase (Decrease) in Temporary Equity                                                  
Issuance of shares (in shares) [1]                 194,104 24,647                              
Issuance of shares                 $ 1,050 $ 200                              
Ending balance (in shares) at Apr. 30, 2023 [1] 18,863,090                                                
Ending balance at Apr. 30, 2023 $ 53,468               3,550 7,700                              
Shares, beginning balance (in shares) at Apr. 24, 2022 [1]                     11,400,833     6,167,254 5,233,579                    
Beginning balance at Apr. 24, 2022 (109,556)       $ (109,556)           $ 1     $ 62 $ (61)   $ 1,711       $ 1,650 $ 61   $ (111,268) $ (111,268)
Increase (Decrease) in Stockholders' Equity                                                  
Net loss (7,525)                                             (7,525)  
Issuance of warrants 1,722                               1,722                
Accretion of cumulative dividends on Series I redeemable convertible preferred stock 0                                                
Change in the redemption value of the redeemable convertible preferred stock 0                                                
Exercise of stock options (in shares) [1]                     21,643                            
Exercise of stock options 66                               66                
Stock-based compensation 295                               295                
Transfer of warrants related to business combination $ 0                                                
Shares, ending balance (in shares) at Apr. 30, 2023 11,422,476                   11,422,476 [1]                            
Ending balance at Apr. 30, 2023 $ (114,998)                   $ 1           3,794             (118,793)  
Increase (Decrease) in Temporary Equity                                                  
Issuance of shares (in shares) [1]             2,126,620                                    
Issuance of shares 19,843           $ 19,843                                    
Accretion of Cumulative Dividends 878                                                
Change in the redemption value of the redeemable convertible preferred stock 1,423                                                
Conversion of cumulative unpaid dividends on Series I redeemable convertible preferred stock to common stock in connection with the reverse recapitalization $ (878)                                                
Conversion of redeemable convertible preferred stock to common stock in connection with the reverse recapitalization (in shares) [1] (20,989,710)                                                
Conversion of redeemable convertible preferred stock to common stock in connection with the reverse recapitalization $ (74,734)                                                
Ending balance (in shares) at Apr. 28, 2024 [1] 0                                                
Ending balance at Apr. 28, 2024 $ 0               $ 0 $ 0                              
Increase (Decrease) in Stockholders' Equity                                                  
Net loss (6,789)                                             (6,789)  
Issuance of warrants 173 $ 24,592                             196 $ 24,592           (23)  
Accretion of cumulative dividends on Series I redeemable convertible preferred stock (878)                               (878)                
Change in the redemption value of the redeemable convertible preferred stock $ (1,423)                               (1,423)                
Exercise of stock options (in shares) 47,395,000                   45,322 [1]                            
Stock-based compensation $ 1,178                               1,178                
Reclassification of liability-classified warrants (894)                               (894)                
Exercise of warrants (in shares) [1]                     296,053 655,213 924,304     20,989,710                  
Exercise of warrants 2,203   $ 5,000 $ 890       $ 74,734               $ 2 2,203   $ 5,000 $ 890     $ 74,732    
Conversion of cumulative unpaid dividends on Series I redeemable convertible preferred stock to common stock in connection with the reverse recapitalization (in shares) [1]                     87,755                            
Conversion of cumulative unpaid dividends on Series I redeemable convertible preferred stock to common stock in connection with the reverse recapitalization 878                               878                
Issuance of common stock in the reverse recapitalization pursuant to the BCA (in shares) [1]                     5,447,203                            
Issuance of common stock in the reverse recapitalization pursuant to the BCA 0                   $ 1           (1)                
Transfer of warrants related to business combination (29,824)                               (29,824)                
Transaction costs incurred in connection with the reverse recapitalization and registration statements (23,958)                               (23,958)                
Issuance of common stock as payment for Legacy Pinstripes transaction costs incurred in connection with the reverse recapitalization (in shares) [1]                     50,000                            
Issuance of common stock as settlement for the unpaid accrued interest on the convertible notes (in shares) [1]                     13,749                            
Issuance of common stock as settlement for the unpaid accrued interest on the convertible notes 138                               138                
Prior period adjustment $ (178)                                             (178)  
Issuance of common stock related to the close of the business combination (in shares) [1]                     156,000                            
Shares, ending balance (in shares) at Apr. 28, 2024 40,087,785                   40,087,785 [1]                            
Ending balance at Apr. 28, 2024 $ (69,156)                   $ 4           $ 56,623             $ (125,783)  
Shares, beginning balance (in shares) at Dec. 28, 2023 17,422,009                                                
Shares, ending balance (in shares) at Dec. 29, 2023 39,918,036                                                
[1] The number of shares of Redeemable Convertible Preferred Stock and Common Stock issued and outstanding prior to the Reverse Recapitalization have been retroactively adjusted by the Exchange Ratios to give effect to the Reverse Recapitalization. See Note 3.